Investigating the best timing for starting medication in pregnant women with gestational diabetes
Gestational Diabetes and Pharmacotherapy (GAP) – A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes
This study is looking at the best time to start medication for pregnant women with gestational diabetes when diet and exercise aren't enough, to help improve health for both moms and babies while also considering their emotional well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11040297 on NIH RePORTER |
What this research studies
This research focuses on gestational diabetes, a condition affecting many pregnancies, and aims to determine the optimal timing for initiating pharmacotherapy when medical nutrition therapy and exercise are insufficient. The study will involve a randomized controlled trial where participants will receive different timings for medication initiation based on their glucose levels. By analyzing maternal and neonatal outcomes, the research seeks to establish evidence-based guidelines that could improve treatment consistency and effectiveness. Patients will be monitored for both physical health outcomes and psychological impacts, such as anxiety and depression.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women diagnosed with gestational diabetes who are struggling to manage their condition with diet and exercise alone.
Not a fit: Patients who are not pregnant or those who have well-controlled gestational diabetes through diet and exercise may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for both mothers and their babies by providing clearer guidelines for pharmacotherapy in gestational diabetes.
How similar studies have performed: Previous research has indicated that earlier initiation of pharmacotherapy can improve neonatal outcomes, suggesting that this approach may be promising.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Palatnik, Anna — Medical College of Wisconsin
- Study coordinator: Palatnik, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.